Search

everythinglearnresearchcommunity

for

Search:↓

Platelet-rich plasma treatment significantly increased hair regrowth and decreased discomfort in alopecia patients, making it a potentially better and safer treatment option.

Steroids help hair regrowth, and minoxidil slows post-steroid hair loss, but effects are temporary.

Trichoscopy helps diagnose and monitor alopecia areata by looking at a combination of specific hair and scalp features.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

People with alopecia areata often have lower levels of vitamin D, zinc, and folate, but more research is needed to understand if supplements can help treat it.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

People with hair loss conditions experience more anxiety, depression, and a lower quality of life than those without these conditions.

Plasmacytoid dendritic cells are a key factor in causing hair loss in alopecia areata and could help differentiate it from other hair loss conditions.

Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.

Monochromatic light devices, especially the 308-nm excimer laser, are promising for treating alopecia areata but more research is needed.

Use specific tools to measure quality of life in alopecia areata patients and improve future treatments.

Apremilast did not work for treating severe alopecia areata.

New treatments for hair loss are showing promise due to better understanding of genetics and the immune system.

Laser and light therapies, especially the 308 nm excimer laser, are effective and safe for treating alopecia areata, but more research is needed.

PRP did not significantly regrow hair in alopecia areata totalis patients.

Treating alopecia areata every 3 weeks with diphenylcyclopropenone is more effective than weekly treatments.

Rare changes in the KRT82 gene are linked to a higher risk of Alopecia Areata.

Tofacitinib improves nail conditions in patients with severe hair loss and does not affect hair regrowth.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

Both dermatologists and patients in Japan agree that treatment success for alopecia areata is having 20% or less scalp hair loss.

White hairs often regrow in alopecia areata patches.

CD2 might be a new treatment target for patchy alopecia areata.

Researchers found four genes that could help diagnose severe alopecia areata early.

Immunization and throat bacteria may increase the risk of a hair loss condition called alopecia areata.

Certain genetic variants linked to immune response increase the risk of alopecia areata in Taiwanese people.

The analysis aims to identify the most effective and safest treatments for alopecia areata.

Azathioprine may help treat severe alopecia areata, but more research is needed.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

In Denmark from 1995 to 2016, hospital-treated alopecia areata cases increased, mostly affecting women and those over 50.

An 18-year-old with hair loss saw hair regrowth after treatments combining microneedling, cupping, medication, and oil application.